Earnings Call · Q1 FY2025·2025-05-13

Q1 25EPS +12.73%·Rev n/aQ4 24EPS -69.49%·Rev n/aQ3 24EPS -66.67%·Rev n/aQ2 24EPS -36.00%·Rev n/a⚠ consensus missing

Acumen Pharmaceuticals, Inc. ABOS

Alex Braun — Head of Investor Relations

Dan O'Connell — Chief Executive Officer

Matt Zuga — Chief Financial Officer and Chief Business Officer

0.0%1d on move date−0.7% vs SPY3d−3.8%5d+1.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABOS calls or request research access.

More ABOS calls Browse calls Request research access